223 related articles for article (PubMed ID: 24897301)
21. CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases.
Mir H; Singh R; Kloecker GH; Lillard JW; Singh S
Oncotarget; 2015 Apr; 6(12):9985-98. PubMed ID: 25888629
[TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.
Hald SM; Kiselev Y; Al-Saad S; Richardsen E; Johannessen C; Eilertsen M; Kilvaer TK; Al-Shibli K; Andersen S; Busund LT; Bremnes RM; Donnem T
BMC Cancer; 2015 May; 15():441. PubMed ID: 26021984
[TBL] [Abstract][Full Text] [Related]
23. Human trophoblasts recruited T lymphocytes and monocytes into decidua by secretion of chemokine CXCL16 and interaction with CXCR6 in the first-trimester pregnancy.
Huang Y; Zhu XY; Du MR; Li DJ
J Immunol; 2008 Feb; 180(4):2367-75. PubMed ID: 18250446
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas.
Held-Feindt J; Rehmke B; Mentlein R; Hattermann K; Knerlich F; Hugo HH; Ludwig A; Mehdorn HM
Glia; 2008 May; 56(7):764-74. PubMed ID: 18293410
[TBL] [Abstract][Full Text] [Related]
25. The CXCL16-CXCR6 chemokine axis in glial tumors.
Hattermann K; Held-Feindt J; Ludwig A; Mentlein R
J Neuroimmunol; 2013 Jul; 260(1-2):47-54. PubMed ID: 23628207
[TBL] [Abstract][Full Text] [Related]
26. Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease.
Hu ZB; Chen Y; Gong YX; Gao M; Zhang Y; Wang GH; Tang RN; Liu H; Liu BC; Ma KL
Int J Med Sci; 2016; 13(11):858-867. PubMed ID: 27877078
[No Abstract] [Full Text] [Related]
27. The prognostic significance of CXCL16 and its receptor C-X-C chemokine receptor 6 in prostate cancer.
Richardsen E; Ness N; Melbø-Jørgensen C; Johannesen C; Grindstad T; Nordbakken C; Al-Saad S; Andersen S; Dønnem T; Nordby Y; Bremnes RM; Busund LT
Am J Pathol; 2015 Oct; 185(10):2722-30. PubMed ID: 26272362
[TBL] [Abstract][Full Text] [Related]
28. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.
Gutwein P; Schramme A; Sinke N; Abdel-Bakky MS; Voss B; Obermüller N; Doberstein K; Koziolek M; Fritzsche F; Johannsen M; Jung K; Schaider H; Altevogt P; Ludwig A; Pfeilschifter J; Kristiansen G
Eur J Cancer; 2009 Feb; 45(3):478-89. PubMed ID: 19070478
[TBL] [Abstract][Full Text] [Related]
29. Chemokine CXCL16, a scavenger receptor, induces proliferation and invasion of first-trimester human trophoblast cells in an autocrine manner.
Huang Y; Zhu XY; Du MR; Wu X; Wang MY; Li DJ
Hum Reprod; 2006 Apr; 21(4):1083-91. PubMed ID: 16431903
[TBL] [Abstract][Full Text] [Related]
30. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction.
Sawada S; Harada K; Isse K; Sato Y; Sasaki M; Kaizaki Y; Nakanuma Y
Pathol Int; 2007 Oct; 57(10):652-63. PubMed ID: 17803654
[TBL] [Abstract][Full Text] [Related]
31. Human gingival fibroblasts express functional chemokine receptor CXCR6.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
Clin Exp Immunol; 2009 Jun; 156(3):413-8. PubMed ID: 19438592
[TBL] [Abstract][Full Text] [Related]
32. The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas.
Li G; Hattermann K; Mentlein R; Mehdorn HM; Held-Feindt J
Oncol Rep; 2013 Feb; 29(2):563-70. PubMed ID: 23229614
[TBL] [Abstract][Full Text] [Related]
33. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer.
Deng L; Chen N; Li Y; Zheng H; Lei Q
Biochim Biophys Acta; 2010 Aug; 1806(1):42-9. PubMed ID: 20122997
[TBL] [Abstract][Full Text] [Related]
34. Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16-CXCR6 axis.
Takiguchi G; Nishita M; Kurita K; Kakeji Y; Minami Y
Cancer Sci; 2016 Mar; 107(3):290-7. PubMed ID: 26708384
[TBL] [Abstract][Full Text] [Related]
35. CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow.
Airoldi I; Cocco C; Morandi F; Prigione I; Pistoia V
Cancer Immunol Immunother; 2008 Apr; 57(4):541-8. PubMed ID: 17786442
[TBL] [Abstract][Full Text] [Related]
36. CXCR6-CXCL16 interaction in the pathogenesis of Juvenile Idiopathic Arthritis.
Martini G; Cabrelle A; Calabrese F; Carraro S; Scquizzato E; Teramo A; Facco M; Zulian F; Agostini C
Clin Immunol; 2008 Nov; 129(2):268-76. PubMed ID: 18760678
[TBL] [Abstract][Full Text] [Related]
37. CXCL16 haplotypes in patients with human carotid atherosclerosis: preliminary results.
Zivković M; Djurić T; Stojković L; Jovanović I; Končar I; Davidović L; Veljković N; Alavantić D; Stanković A
J Atheroscler Thromb; 2015; 22(1):10-20. PubMed ID: 25142184
[TBL] [Abstract][Full Text] [Related]
38. CXCL16 and CXCR6 in Ewing sarcoma family tumor.
Na KY; Kim HS; Jung WW; Sung JY; Kalil RK; Kim YW; Park YK
Hum Pathol; 2014 Apr; 45(4):753-60. PubMed ID: 24507753
[TBL] [Abstract][Full Text] [Related]
39. CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway.
Wang J; Lu Y; Wang J; Koch AE; Zhang J; Taichman RS
Cancer Res; 2008 Dec; 68(24):10367-76. PubMed ID: 19074906
[TBL] [Abstract][Full Text] [Related]
40. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease.
Morgan AJ; Guillen C; Symon FA; Huynh TT; Berry MA; Entwisle JJ; Briskin M; Pavord ID; Wardlaw AJ
Clin Exp Allergy; 2005 Dec; 35(12):1572-80. PubMed ID: 16393323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
